Strumento inattivo

Azioni Ardea Biosciences, Inc.

Azioni

Prezzo di chiusura Nasdaq Altri mercati azionari
- ^USD	-

SANOFI : AstraZeneca hungry to refill medicine cabinet	30/06/12
SANOFI : GSK goes hostile with $2.6 billion Human Genome offer	09/05/12
Ardea Biosciences, Inc. : Biotech targets fight back as Big Pharma circles	02/05/12
Ardea Biosciences, Inc. : Securities Lawyers at Goldfarb LLP Seeking More Money, Information for Stockholders of Ardea Biosciences, Inc.	01/05/12
Ardea Biosciences, Inc. : Warner Chilcott to explore sale of company	30/04/12

Settore

	Variaz. 1 gen.	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	-3,46%	102 Mrd
REGENERON PHARMACEUTICALS, INC.	+1,41%	96,29 Mrd
ARGENX SE	+2,13%	22,18 Mrd
BIONTECH SE	-15,84%	21,2 Mrd
GENMAB A/S	-9,21%	18,31 Mrd
WUXI APPTEC CO., LTD.	-39,98%	17,38 Mrd
BEIGENE, LTD.	-14,65%	16,36 Mrd
NEUROCRINE BIOSCIENCES, INC.	+4,39%	13,97 Mrd
SAREPTA THERAPEUTICS, INC.	+31,35%	12,17 Mrd